Last updated on December 2nd, 2025 at 12:54 am
| Check Paras Healthcare filing with SEBI. | Paras Healthcare IPO allotment status |
Paras Healthcare operates a network of multi-specialty tertiary hospitals across North and East India, focusing on making advanced medical care accessible and affordable.
The company’s IPO aims to raise approximately ₹400 crore via a fresh issue along with an offer-for-sale of 14,974,010 shares, providing investors an opportunity to participate in India’s growing healthcare sector.
Subscription date to apply for Paras Healthcare TBA. Price band for the IPO is yet to be announced.
Revenue, PAT, EBITDA of Paras Healthcare
| Year | FY 2024 |
| Networth | ~ ₹ 338.50 Cr |
| Revenue: | ~ ₹ 1129.03 Cr |
| EBITDA | ~ ₹ 154.41 Cr |
| PAT | ~ ₹ -15.33 Cr |
| EBITDA Margin: | ~ 13.68% |
| PAT Margin | -1.36% |
Paras Healthcare Financials (Consolidated Figures)
| Year (Approx Values) | Revenue (₹ Cr) | Profit (₹ Cr) | Assets (₹ Cr) | Net Worth (₹ Cr) |
| 2022 | ₹ 779.9 | ₹ -14.8 | ₹ 963.5 | ₹ 73.1 |
| 2023 | ₹ 917.9 | ₹ -42.8 | ₹ 1,293.1 | ₹ 30.1 |
| 2024 | ₹ 1,129.0 | ₹ -15.3 | ₹ 1,477.7 | ₹ 338.5 |
Paras Healthcare IPO Grey market premium today
| Date | IPO Price | IPO GMP | GMP Trend | Estimated listing | Estimated profit per lot |
| 26-Nov | ₹ 0-0 | ₹ Not yet | – | ₹ – | ₹ |
| 25-Nov | ₹ 0-0 | ₹ – | – | ₹ – | ₹ |
| 24-Nov | ₹ 0-0 | ₹ – | – | ₹ – | ₹ |
| 23-Nov | ₹ 0-0 | ₹ – | – | ₹ – | ₹ |
| 22-Nov | ₹ 0-0 | ₹ – | – | ₹ – | ₹ |
Paras Healthcare IPO Pros & Cons
Strengths:
- Strong presence in North & East India with growing hospital network.
- Focus on underserved Tier-II & Tier-III cities.
- Consistent revenue growth and improving margins.
- Expansion in high-demand healthcare segments.
- Experienced management with proven operational track record.
Risks:
- Loss-making company with negative PAT.
- High competition from established hospital chains.
- Rising operational and finance costs.
- Heavy dependence on a few key hospitals.
- Regulatory and compliance risks in healthcare sector.
IPO date & invest detail
| IPO Open Date: | Dec 2025 |
| IPO Close Date: | TBA |
| Anchor Investor Bidding | TBA |
| IPO Allotment Date: | TBA |
| Refunds & Demat Credit | TBA |
| Tentative Listing Date: | Dec 2025 |
| IPO Category | Mainboard |
| Symbol | |
| Face Value: | Rs. 01 per Equity Share |
| Issue Size: | Fresh issue of ~₹ 400 crore + Offer-for-Sale of ~14,974,010 Equity shares |
| Lot Size: | TBA |
Paras Healthcare IPO Composition & Proceeds
| Fresh Issue: | ~ ₹ 400 Crore |
| Offer for Sale: | ~14,974,010 Equity shares |
| Employee reservation | – |
| Price Range | TBA |
| Use of Proceeds: | |
| Borrowing payment | ~ ₹ 217.96 Cr |
| Working Capital Requirement | ~ ₹ 82.04 Cr |
| General Corporate Purpose | Balance |
| Technology & Infrastructure | NA |
| IPO Listing on: | BSE – NSE |
| Retail Quota: | ≤ 10% |
| QIB Quota: | ≥ 75% |
| NII Quota: | ≤ 15% |
Paras Healthcare Lot Size details
| Application Type | Lot Size | No. of Lots | No. of Shares | Investment Amount |
| Retail(Min) | TBA | 1 | TBA | ₹ – |
| Retail (Max) | TBA | 13 | TBA | ₹ – |
| Small HNI (Min) | TBA | 14 | TBA | ₹ – |
| Small HNI (Max) | TBA | 66 | TBA | ₹ – |
| Big HNI (Min) | TBA | 67 | TBA | ₹ – |
Core Offerings of Paras Healthcare
It delivers specialised tertiary medical care services—covering cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and joint replacement—primarily in underserved Tier-II and Tier-III cities.
Paras Healthcare Promoters – Pre offer equity (Approx)
| Dr. Dharminder Kumar Nagar | ~75.32% |
| Commelina Ltd. | ~24.68% |
Lead Managers / Registrars of Paras Healthcare
| Lead / Book Running Lead Managers | ICICI Securities Limited, IIFL Securities Limited, Motilal Oswal Investment Advisors Limited |
| Registrar (RTA) | Link Intime India Private Limited (MUFG) |
Founding Year & Managing Director
The company was incorporated in the year 1987.
Dr. Dharminder Kumar Nagar is the Managing Director & Promoter who has spearheaded the company’s expansion since its inception.
Paras Healthcare FAQ
Q1. What is the business of Paras Healthcare?
Paras Healthcare operates a chain of multi-specialty hospitals offering advanced medical services like cardiology, oncology, neurosciences, orthopaedics, and gastro sciences, primarily in Tier-II and Tier-III cities.
Q2. Why is the company raising funds via IPO?
The company is raising funds via IPO to repay debts, fund new hospital expansions, and meet general corporate purposes.
Q3. What is the issue size and where will it be listed?
The IPO size is around ₹400 crore (fresh issue) plus an offer-for-sale of 14,974,010 Equity shares & it will be listed on BSE and NSE.
Q4. What are the risks to an investor?
The IPO Risk includes continued losses, intense competition, high operating costs, and healthcare regulatory changes that may affect margins.
Q5. What are the potential upsides?
Positive side to apply for the IPO include strong regional presence, scalable business model, expanding healthcare demand, and potential profitability improvement.
Q6. How to apply for the IPO?
Investors can apply for the IPO through ASBA-enabled bank accounts or UPI-based online platforms offered by brokers.
Q 7. When is the tentative listing date?
Expected listing date is yet to be announced
For more amazing blogs click here (IPO Corner)
For the latest upcoming IPO Calendar.
For further information you can visit official website of Paras Healthcare.